T he rate of diabetes mellitus (DM) diagnoses in the United States is increasing. 1 Approximately 24% to 48% of patients with DM have gastroparesis.
His social history included a 90-pack-per-year smoking habit, which he quit 5 years previously, and occasional marijuana use, but he denied any other illicit drug or alcohol use. He occasionally drank caffeinated beverages. He received disability payments and was in a long-term relationship.
Treatment Course
The patient continued to receive the standard of care for diabetic gastroparesis, which included metoclopramide.
In addition, he was scheduled to undergo 6 sessions of OMT. Before the first appointment, 2 weeks after the third appointment, and after the sixth appointment, the patient was asked to fill out the GCSI survey.
Owing to the patient's extensive medical history, multiple comorbidities, and fragile state, the researchers conducted a structural examination of all body regions at the initial visit but restricted treatment to the 4 diaphragms regardless of the somatic dysfunctions noted.
This protocol ensured that the fluids were able to flow freely without restriction at the choke points and that the patient was not overtreated. At each visit, the patient was reassessed using structural examinations to gauge the effects of the previous treatment and then treated for any apparent somatic dysfunctions. 
Report of Case
A 49-year-old white man with type 1 DM presented with nausea, which was worse in the morning and which he described as lasting 5 to 7 days per week for the past several years. He had been hospitalized approximately every 6 to 8 weeks for dehydration, nausea, and vomiting. The patient also reported an intermittent decrease in appetite and headaches once per week, which were relieved with ibuprofen. He also complained of right shoulder pain. He denied fevers, chills, night sweats, syncope, chest pain, palpitations, exertional dyspnea, cough, shortness of breath, hematemesis, or changes in bowel or bladder habits, sleeping habits, vision, and weight.
He was currently taking metoclopramide for his diabetic gastroparesis, but it did not relieve his symptoms.
He had "tried everything that you can imagine in the past" for the condition without relief. Other medications included amlodipine, aspirin, atorvastatin, insulin aspart (subcutaneous), levothyroxine, losartan, metoprolol succinate (extended release), and sertraline.
The patient had multiple complications of type 1 DM, including coronary artery disease, diabetic gastroparesis diagnosed 3 years previously, diabetic retinopathy, occipital release; and rib raising were performed. Subsequent decreased bogginess and tension in the suboccipital region, increased respiration down to the pelvis, and decreased discomfort were observed.
OMT Session 2 (Week 6)
The patient reported overall improvement, with no adverse effects of the OMT. His nausea had resolved for 2 weeks after the first session, and then he had minimal nausea for 4
weeks. The pain in his right shoulder had lessened after the first OMT session. Although his appetite was normal, he was unable to eat solid foods because 4 teeth had been extracted between appointments. The remainder of the physical examination results were unremarkable. 
OMT
Ligamentous articular release was applied to the lower extremity. Decompression of the OA joint was successful. After treatment, cranial rhythm increased. Also, the lower extremity was notably less tender and demonstrated increased range of motion.
OMT Session 3 (Week 10)
For 2 weeks after the second treatment session, the patient reported feeling good, with no nausea or vomiting.
In the past month he had 1 episode of nausea, vomiting, and dry heaving, which required hospitalization for dehydration 2 weeks after the second session. Potassium
The patient completed the GCSI survey at the introduc- 
OMT Session 1 (Week 2)
The patient was a thin man of pleasant demeanor and was 
OMT Session 4 (Week 13)
The patient reported feeling good and that his physical activity, energy, and appetite had increased. In the past 3 weeks, he woke up with nausea on only 2 occasions. His shoulder pain had decreased and no longer awakened him at night. Between the third and the current OMT 
OMT Session 6 (Week 17)
The patient reported no nausea or vomiting since his last appointment; he had been nausea-free for more than a month. He also had no migraines for approxi- OMT techniques were applied to the cervical, thoracic, abdominal, and pelvic diaphragms, the patient was free from nausea and vomiting for 2 weeks. Two weeks after his third session, he had 2 days of nausea and then was nausea-free for the duration of the study (>6 weeks). Furthermore, the patient had been hospitalized approximately every 6 to 8 weeks before the study; but throughout the duration of the 6-month
Final Assessment (Week 19) Two weeks after the last OMT session, the patient filled out the final GCSI questionnaire (Table) . He expressed a desire to continue receiving OMT because it was the only treatment that seemed to relieve his symptoms and not produce adverse effects.
Discussion
The vagus nerve exits the skull through the jugular foramen between the occipital and temporal bones. The thoracic duct lies between the aorta and the right crus of the diaphragm; thus, if the diaphragm is flattened, lymphatic drainage through the thoracic duct is decreased, and the resulting buildup of fluid in the abdominal cavity and its organs hinders their ability to work effectively. 8 A buildup of waste products can decrease circulation, oxygenation, and nutrition to tissues and organs.
Because external structures and tissues may influence the diaphragm and cause dysfunction, it is important to examine all of these regions for somatic dysfunction.
With a history of fractured lower right ribs, the patient was more susceptible to diaphragm dysfunction and may have needed a longer time to resolve these somatic dys-
